Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?
Abstract In recent years, the development of targeted therapies for tumors with KRAS mutations has progressed rapidly, rendering the notion of KRAS as “undruggable” outdated. However, targeted therapies for KRAS mutations still face numerous challenges, including resistance, efficacy concerns, toxic...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2025-07-01
|
| Colección: | Journal of Experimental & Clinical Cancer Research |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s13046-025-03444-1 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|